Ушбу иш иқтибос қилган ишлар

161 та иш

Иш: Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning +7
Мақола20248 иқтибос
ABI
Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
Mahdi Rafiyan, Mohammad Hassan Jafari Najaf Abadi, Seyed Saeed Tamehri Zadeh +3
Шарҳ мақола20227 иқтибос
ABI
Prospective identification of tumorigenic breast cancer cells
Muhammad Al‐Hajj, Max S. Wicha, Adalberto Benito‐Hernández +2
Мақола20037 иқтибос
ABI
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou +5
Шарҳ мақола20257 иқтибос
ABI
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee +24
Мақола20206 иқтибос
ABI
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Haksoo Lee, Byeongsoo Kim, Junhyeong Park +7
Шарҳ мақола20256 иқтибос
ABI
Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions
Kaveh Hadiloo, Parsa Mostanadi, Ali Asadzadeh +2
Шарҳ мақола20256 иқтибос
ABI
The Efficacy of Decision Aids on Enhancing Early Cancer Screening: A Meta‐Analysis of Randomized Controlled Trials
Yang Chen, Linna Li, Xiaoli Chen +2
Шарҳ мақола20255 иқтибос
ABI
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang +2
Шарҳ мақола20245 иқтибос
ABI
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li +7
Шарҳ мақола20245 иқтибос
ABI
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Шарҳ мақола20235 иқтибос
ABI
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
Shiqi Li, Sikai Ling, Dawei Wang +17
Мақола20245 иқтибос
ABI
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Shuo Zhang, Rui Yang, Yujie Ouyang +3
Мақола20245 иқтибос
ABI
Drug resistance and Cancer stem cells
Yuan Li, Zhenning Wang, Jaffer A. Ajani +1
Шарҳ мақола20215 иқтибос
ABI
The clinical landscape of CAR NK cells
Lasse Vedel Jørgensen, Emil Birch Christensen, Mike Bogetofte Barnkob +1
Шарҳ мақола20255 иқтибос
ABI
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis +6
Мақола20174 иқтибос
ABI
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho +1
Шарҳ мақола20224 иқтибос
ABI
M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2/HIF-1α axis mediated metabolic reprogramming of macrophages
Yingying Zhang, Liangyu Zhu, Xueqin Li +6
Мақола20234 иқтибос
ABI
Melatonin for gastric cancer treatment: where do we stand?
Mahdi Rafiyan, Elham Tootoonchi, Mahdieh Golpour +6
Шарҳ мақола20244 иқтибос
ABI
Circular RNAs and Cancers
Mohammad Mahdi Heidari, Mohammad Saeid Moeinfar, Mahdi Rafiyan +9
Шарҳ мақола20254 иқтибос
ABI
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber, Leo D. Wang
Шарҳ мақола20224 иқтибос
ABI
Diagnostic technologies for neuroblastoma
Leena Khelifa, Yubing Hu, Jennifer Tall +11
Шарҳ мақола20254 иқтибос
ABI
Dynamic joint prediction model of severe radiation-induced oral mucositis among nasopharyngeal carcinoma: a prospective longitudinal study
Juejin Li, Hong He, Chang Guan +2
Мақола20253 иқтибос
ABI
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Шарҳ мақола20203 иқтибос
ABI
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases
Agata Kieliszek, Daniel Mobilio, Deepak Upreti +10
Мақола20233 иқтибос
ABI